✦ LIBER ✦

Schmallenberg virus: a novel viral disease in northern Europe

✍ Scribed by Gibbens, N.

Book ID: 111939556
Publisher: British Veterinary Association
Year: 2012
Tongue: English
Weight: 69 KB
Volume: 170
Category: Article
ISSN: 0042-4900
DOI: 10.1136/vr.e292

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

‘Schmallenberg virus’ – a novel orthobun

‘Schmallenberg virus’ – a novel orthobunyavirus emerging in Europe

✍ BEER, M.; CONRATHS, F. J.; VAN DER POEL, W. H. M. 📂 Article 📅 2012 🏛 Cambridge University Press 🌐 English ⚖ 169 KB

Schmallenberg virus infection in small r

Schmallenberg virus infection in small ruminants – First review of the situation and prospects in Northern Europe

✍ K. Lievaart-Peterson; S.J.M. Luttikholt; R. Van den Brom; P. Vellema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Schmallenberg virus, a novel orthobunyav

Schmallenberg virus, a novel orthobunyavirus infection in ruminants in Europe: Potential global impact and preventive measures

✍ Conraths, FJ; Peters, M; Beer, M 📂 Article 📅 2013 🏛 New Zealand Veterinary Association 🌐 English ⚖ 766 KB

Establishment of a reverse genetics syst

Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in Europe

✍ Elliott, R. M.; Blakqori, G.; van Knippenberg, I. C.; Koudriakova, E.; Li, P.; M 📂 Article 📅 2013 🏛 Society for General Microbiology 🌐 English ⚖ 731 KB

Detection, distribution and control of P

Detection, distribution and control of Potato mop-top virus, a soil-borne virus, in northern Europe

✍ J. Santala; O. Samuilova; A. Hannukkala; S. Latvala; H. Kortemaa; U. Beuch; A. K 📂 Article 📅 2010 🏛 Association of Applied Biologists 🌐 English ⚖ 857 KB

Hepatitis D virus infection—Not a vanish

Hepatitis D virus infection—Not a vanishing disease in Europe!

✍ Heiner Wedemeyer; Benjamin Heidrich; Michael P. Manns 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

We thank Drs. Dore and Micallef for their comments on our manuscript discussing the lower risk of HCV reinfection among previously infected injection drug users (IDUs). 1 We acknowledge that there are a number of limitations associated with our retrospective study design. They also suggest that the